ETHOSUXIMIDE
- Product NDC
- 0121-0670
- 11-digit product format
- 001210670
- Labeler code
- 0121
- Product ID
- 0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ETHOSUXIMIDE
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- ANDA040253
- Marketing category
- ANDA
- Marketing start
- 2000-11-22
- Substance
- ETHOSUXIMIDE
- Active strength
- 250 mg/5mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ETHOSUXIMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETHOSUXIMIDE | 250 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5SEH9X1D1D |
| Rxcui | 251322 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0121-0670-16 | ETHOSUXIMIDE | 473 mL in 1 BOTTLE | SOLUTION | 473 | | 17 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ETHOSUXIMIDE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0121-0670 | ETHOSUXIMIDE SOLUTION [PAI HOLDINGS, LLC DBA PAI PHARMA] | 16 | Current NDC, Legacy NDC, 1 package rows | 20250326_8a5cc930-0b36-48a8-9ad0-de633b208742.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0121-0670-16 | 00121067016 | 473 mL in 1 BOTTLE (0121-0670-16) | 473 ml | 2000-11-22 | 0000-00-00 | No | No | Current |